Platelet membrane coated resiquimod nanoparticles (Cello Therapeutics)

血小板膜包被的瑞喹莫德纳米颗粒 (Cello Therapeutics)

Report date: 2026/01/21 20:00:47

Base Information

Drug NamePlatelet membrane coated resiquimod nanoparticles (Cello Therapeutics)
Drug Alias NamePNP-R848CE120CE-120
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 8 agonistsToll like receptor 7 agonists
TargetsToll like receptor 8Toll like receptor 7
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCello Therapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A